Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Oncology

Study reveals non-statin cholesterol drugs could reduce liver cancer risk

Study reveals non-statin cholesterol drugs could reduce liver cancer risk
p p Read More

The third leading cause of cancer mortality accounts for over 700,000 deaths every year

August 2, 2024 liver cancer, National Cancer Institute, News, non-statin cholesterol drugs, Oncology

Researchers reveal CAR-enhancer therapy could help overcome cancer relapse

Researchers reveal CAR-enhancer therapy could help overcome cancer relapse
p p Read More

Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer […]

August 2, 2024 Cancer, CAR T cells, CAR-E therapy, Dana-Farber Cancer Institute, News, Oncology

Study finds ovarian cancer-treated women less likely to develop breast cancer

Study finds ovarian cancer-treated women less likely to develop breast cancer
p p Read More

Combined, ovarian and breast cancer affect over 60,000 women in the UK every year

August 1, 2024 Breast Cancer, Manchester University NHS Foundation Trust, News, Oncology, Ovarian Cancer

Apollo and Oxford University enter drug discovery and development collaboration

Apollo and Oxford University enter drug discovery and development collaboration
p p Read More

The latest collaboration marks Apollo’s sixth agreement with a research institution

July 31, 2024 Apollo Therapeutics, autoimmune diseases, drug discovery, News, Oncology, university of oxford

ICL study finds single bowel screening test can reduce chances of developing cancer

ICL study finds single bowel screening test can reduce chances of developing cancer
p p Read More

Affecting over 250,000 people, bowel cancer is the fourth most common cancer in the UK

July 24, 2024 Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, flexible sigmoldoscopy screening, Imperial College London, News, Oncology

Study reveals new AI tool predicts recurrence of prostate cancer by a decade

Study reveals new AI tool predicts recurrence of prostate cancer by a decade
p p Read More

The most commonly diagnosed cancer in men in the UK leads to over 12,000 annual deaths

July 18, 2024 artificial intelligence, Institute of Cancer Research, News, Oncology, prostate cancer, Royal Marsden NHS Foundation Trust

US study reveals Co-STAR receptor cells show promise in treating cancers

US study reveals Co-STAR receptor cells show promise in treating cancers
p p Read More

The most globally prevalent cancers include breast, lung, bowel and prostate cancers

July 17, 2024 Bloomberg-Kimmel Institute for Cancer Immunotherapy, Cancer, co-stimulatory synthetic T-cell receptor and antigen receptor, John Hopkins Ludwig Center, Johns Hopkins Kimmel Center, Lustgarten Laboratory, News, Oncology

Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments

Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments
p p Read More

Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer

July 9, 2024 ADCs, Francis Crick Institute, Imperial College London, Myricx Bio, News, Oncology

Study reveals genetic mutations associated with aggressive prostate cancer

Study reveals genetic mutations associated with aggressive prostate cancer
p p Read More

Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses

July 4, 2024 aggressive prostate cancers, Institute of Cancer Research, News, Oncology, prostate cancer, UK Genetic Prostate Cancer Study

ICL granted £150,000 to explore link between breast cancer and breastfeeding

ICL granted £150,000 to explore link between breast cancer and breastfeeding
p p Read More

Breast cancer is the most common cancer in the UK, accounting for 15% of all cancers

July 1, 2024 Breast Cancer, Breast Cancer Now, breastfeeding, Imperial College London, News, Oncology

Posts navigation

Posts pagination

« Previous 1 2 3 4 … 9 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy